Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Unity Biotechnology Q2 EPS $(0.19) Up From $(0.32) YoY

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.19) per share. This is a 40.63 percent increase over losses of $(0.32) per share from the same period last year.
byBill Haddad
August 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.19) per share. This is a 40.63 percent increase over losses of $(0.32) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts